that makes FDA-approved medicines with semaglutide
Skipping ahead to higher doses to lose weight faster is one of the strongest predictors of severe muscle loss in clinical observation
Outsourcing facilities (503B) register with the FDA and are subject to federal inspection, though FDA registration alone does not constitute FDA approval of the compounded products themselves
Jenn and I discuss: How natural GLP-1 production can decline with age Why under-fueling is still the primary issue for many athletes Different types and forms of GLP-1 meds Who should (and shouldn't) consider these medications Potential risks of GLP-1 use, including muscle loss, bone density loss, and GI distress Potential benefits to inflammation, autoimmune conditions, gut health, and mood Nutrition and supplement strategies when appetite is lower Dosing and microdosing for therapeutic use, not just weight loss Why some athletes cycle on and off these meds, or may only need them for a short period of time Why Jenn takes most clients off GLP-1s during race training The stigma around GLP-1 use among athletes Jenn's own story: early menopause, a cardiovascular family history, and how a short course changed her running Why solid diet and lifestyle habits must always come first I hope this episode helps you better understand the complexities of GLP-1 medications in endurance athletes, and why there's rarely a simple yes-or-no answer to the questions we explore together
The GLP-1 framing isnt just marketingEriomin does appear to support GLP-1 production in studies, and the Morosil has some interesting weight loss data
Understanding Retatrutide A Breakthrough Triple-Action Approach A lot of the confusion starts here
